期刊论文详细信息
Epigenetics & Chromatin
Focused, high accuracy 5-methylcytosine quantitation with base resolution by benchtop next-generation sequencing
Willard M Freeman1  Arthur S Berg2  Dustin R Masser3 
[1] Genome Sciences Facility, Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA 17033, USA;Department of Public Health Sciences, Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA 17033, USA;Department of Pharmacology, Pennsylvania State University College of Medicine, R130, 500 University Drive, Hershey, PA 17033, USA
关键词: MiSeq;    Next-generation sequencing;    Bisulfite sequencing;    5-methylcytosine;   
Others  :  805362
DOI  :  10.1186/1756-8935-6-33
 received in 2013-07-25, accepted in 2013-09-25,  发布年份 2013
PDF
【 摘 要 】

Background

The growing interest in the role of epigenetic modifications in human health and disease has led to the development of next-generation sequencing methods for whole genome analysis of DNA methylation patterns. However, many projects require targeted methylation analysis of specific genes or genomic regions. We have developed an approach, termed BiSulfite Amplicon Sequencing (BSAS), for hypothesis driven and focused absolute DNA methylation analysis. This approach is applicable both to targeted DNA methylation studies as well as to confirmation of genome-wide studies.

Results

BSAS uses PCR enrichment of targeted regions from bisulfite-converted DNA and transposome-mediated library construction for rapid generation of sequencing libraries from low (1 ng) sample input. Libraries are sequenced using the Illumina MiSeq benchtop sequencer. Generating high levels of sequencing depth (>1,000 ×) provides for quantitatively precise and accurate assessment of DNA methylation levels with base specificity. Dual indexing of sequencing libraries allows for simultaneous analysis of up to 96 samples. We demonstrate the superior quantitative accuracy of this approach as compared to existing Sanger sequencing methods.

Conclusions

BSAS can be applied to any genomic region from any DNA source, including tissue and cell culture. Thus, BSAS provides a new validation approach for rapid and highly quantitative absolute CpG methylation analysis of any targeted genomic regions in a high throughput manner.

【 授权许可】

   
2013 Masser et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140708075231114.pdf 919KB PDF download
Figure 5. 29KB Image download
Figure 4. 17KB Image download
Figure 3. 41KB Image download
Figure 2. 33KB Image download
Figure 1. 55KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】
  • [1]Okano M, Bell DW, Haber DA, Li E: DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
  • [2]Rabinovitz S, Kaufman Y, Ludwig G, Razin A, Shemer R: Mechanisms of activation of the paternally expressed genes by the Prader-Willi imprinting center in the Prader-Willi/Angelman syndromes domains. Proc Natl Acad Sci U S A 2012, 109:7403-7408.
  • [3]Gardiner-Garden M, Frommer M: CpG islands in vertebrate genomes. J Mol Biol 1987, 196:261-282.
  • [4]Bird A: DNA methylation patterns and epigenetic memory. Genes Dev 2002, 16:6-21.
  • [5]Bock C, Tomazou EM, Brinkman AB, Muller F, Simmer F, Gu H, Jager N, Gnirke A, Stunnenberg HG, Meissner A: Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotechnol 2010, 28:1106-1114.
  • [6]Wang RY, Gehrke CW, Ehrlich M: Comparison of bisulfite modification of 5-methyldeoxycytidine and deoxycytidine residues. Nucleic Acids Res 1980, 8:4777-4790.
  • [7]Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL: A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 1992, 89:1827-1831.
  • [8]Dikow N, Nygren AO, Schouten JP, Hartmann C, Kramer N, Janssen B, Zschocke J: Quantification of the methylation status of the PWS/AS imprinted region: comparison of two approaches based on bisulfite sequencing and methylation-sensitive MLPA. Mol Cell Probes 2007, 21:208-215.
  • [9]Mikeska T, Bock C, El-Maarri O, Hubner A, Ehrentraut D, Schramm J, Felsberg J, Kahl P, Buttner R, Pietsch T, Waha A: Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis. J Mol Diagn 2007, 9:368-381.
  • [10]Dupont JM, Tost J, Jammes H, Gut IG: De novo quantitative bisulfite sequencing using the pyrosequencing technology. Anal Biochem 2004, 333:119-127.
  • [11]Parrish RR, Day JJ, Lubin FD: Direct bisulfite sequencing for examination of DNA methylation with gene and nucleotide resolution from brain tissues. Curr Protoc Neurosci 2012., 7Unit 7.24
  • [12]Franca LT, Carrilho E, Kist TB: A review of DNA sequencing techniques. Q Rev Biophys 2002, 35:169-200.
  • [13]Lewin J, Schmitt AO, Adorjan P, Hildmann T, Piepenbrock C: Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinform 2004, 20:3005-3012.
  • [14]Mashayekhi F, Ronaghi M: Analysis of read length limiting factors in pyrosequencing chemistry. Anal Biochem 2007, 363:275-287.
  • [15]Diep D, Plongthongkum N, Gore A, Fung HL, Shoemaker R, Zhang K: Library-free methylation sequencing with bisulfite padlock probes. Nat Methods 2012, 9:270-272.
  • [16]Lee EJ, Pei L, Srivastava G, Joshi T, Kushwaha G, Choi JH, Robertson KD, Wang X, Colbourne JK, Zhang L, Schroth GP, Xu D, Zhang K, Shi H: Targeted bisulfite sequencing by solution hybrid selection and massively parallel sequencing. Nucleic Acids Res 2011, 39:e127.
  • [17]Hodges E, Smith AD, Kendall J, Xuan Z, Ravi K, Rooks M, Zhang MQ, Ye K, Bhattacharjee A, Brizuela L, McCombie WR, Wigler M, Hannon GJ, Hicks JB: High definition profiling of mammalian DNA methylation by array capture and single molecule bisulfite sequencing. Genome Res 2009, 19:1593-1605.
  • [18]Komori HK, LaMere SA, Torkamani A, Hart GT, Kotsopoulos S, Warner J, Samuels ML, Olson J, Head SR, Ordoukhanian P, Lee PL, Link DR, Salomon DR: Application of microdroplet PCR for large-scale targeted bisulfite sequencing. Genome Res 2011, 21:1738-1745.
  • [19]Schroeder DI, Blair JD, Lott P, Yu HO, Hong D, Crary F, Ashwood P, Walker C, Korf I, Robinson WP, Lasalle JM: The human placenta methylome. Proc Natl Acad Sci U S A 2013, 110:6037-6042.
  • [20]Saied MH, Marzec J, Khalid S, Smith P, Down TA, Rakyan VK, Molloy G, Raghavan M, Debernardi S, Young BD: Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats. PLoS ONE 2012, 7:e33213.
  • [21]Sati S, Tanwar VS, Kumar KA, Patowary A, Jain V, Ghosh S, Ahmad S, Singh M, Reddy SU, Chandak GR, Raghunath M, Sivasubbu S, Chakraborty K, Scaria V, Sengupta S: High resolution methylome map of rat indicates role of intragenic DNA methylation in identification of coding region. PLoS ONE 2012, 7:e31621.
  • [22]Pirola L, Balcerczyk A, Tothill RW, Haviv I, Kaspi A, Lunke S, Ziemann M, Karagiannis T, Tonna S, Kowalczyk A, Beresford-Smith B, Macintyre G, Kelong M, Hongyu Z, Zhu J, El-Osta A: Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res 2011, 21:1601-1615.
  • [23]Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G, Cantor CR, Field JK, van den Boom D: Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci U S A 2005, 102:15785-15790.
  • [24]Olkhov-Mitsel E, Bapat B: Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers. Cancer Med 2012, 1:237-260.
  • [25]Adey A, Shendure J: Ultra-low-input, tagmentation-based whole-genome bisulfite sequencing. Genome Res 2012, 22:1139-1143.
  • [26]Song CX, Szulwach KE, Dai Q, Fu Y, Mao SQ, Lin L, Street C, Li Y, Poidevin M, Wu H, Gao J, Liu P, Li L, Xu GL, Jin P, He C: Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell 2013, 153:678-691.
  • [27]Wojdacz TK, Hansen LL, Dobrovic A: A new approach to primer design for the control of PCR bias in methylation studies. BMC Res Notes 2008, 1:54. BioMed Central Full Text
  • [28]Adey A, Morrison HG, Asan Xun X, Kitzman JO, Turner EH, Stackhouse B, MacKenzie AP, Caruccio NC, Zhang X, Shendure J: Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition. Genome Biol 2010, 11:R119. BioMed Central Full Text
  • [29]Booth MJ, Branco MR, Ficz G, Oxley D, Krueger F, Reik W, Balasubramanian S: Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Sci 2012, 336:934-937.
  • [30]Yu M, Hon GC, Szulwach KE, Song CX, Jin P, Ren B, He C: Tet-assisted bisulfite sequencing of 5-hydroxymethylcytosine. Nat Protoc 2012, 7:2159-2170.
  • [31]Hao Y, Huang W, Nielsen DA, Kosten TA: Litter gender composition and sex affect maternal behavior and DNA methylation levels of the oprm1 gene in rat offspring. Front Psychiatry 2011, 2:21.
  • [32]Merbs SL, Khan MA, Hackler L Jr, Oliver VF, Wan J, Qian J, Zack DJ: Cell-specific DNA methylation patterns of retina-specific genes. PLoS ONE 2012, 7:e32602.
  • [33]Bixler GV, Vanguilder HD, Brucklacher RM, Kimball SR, Bronson SK, Freeman WM: Chronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome. BMC Med Genomics 2011, 4:40. BioMed Central Full Text
  • [34]Brucklacher RM, Patel KM, VanGuilder HD, Bixler GV, Barber AJ, Antonetti DA, Lin CM, LaNoue KF, Gardner TW, Bronson SK, Freeman WM: Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response. BMC Med Genomics 2008, 1:26. BioMed Central Full Text
  文献评价指标  
  下载次数:18次 浏览次数:6次